Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot study

Overview of attention for article published in BMC Nephrology, March 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 2,681 followers.

RT @shivadas29: SPL=Spironolactone/aldactone 3g NaCl vs 5g NaCl+SPL vs 3g NaCl+SPL PEP : change in 24 hr urine protein https://t.co/TNq0M0Z…

16 May 2023

Reply Repost Favourite

SPL=Spironolactone/aldactone 3g NaCl vs 5g NaCl+SPL vs 3g NaCl+SPL PEP : change in 24 hr urine protein https://t.co/TNq0M0ZUbz 2022 pilot " It is unnecessary to add on SPL for patients with satisfying sodium restriction, thus avoiding the adverse events

16 May 2023

Reply Repost Favourite

Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot study https://t.co/jfbkiLYTqy

11 Mar 2022

Reply Repost Favourite

New NUTRITION Research Available. Click Here to Access Article(s): https://t.co/zIog5G4JL5

08 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.